C07D 419/00
Heterocyclic compounds containing two or more hetero rings, at least one ring
Official title: Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
C07D419/00 (Heterocyclic compounds containing two or more hetero rings, at least one ring) appears on 246 US grants and 294 published applications in this corpus.
Search patents in C07D- Granted patents
- 246
- Published applications
- 294
- Assignees
- 187
- Inventors
- 1,210
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 5 | 0 |
| 1995 | 3 | 0 |
| 1996 | 5 | 0 |
| 1997 | 3 | 0 |
| 1998 | 7 | 0 |
| 1999 | 5 | 0 |
| 2000 | 6 | 0 |
| 2001 | 5 | 0 |
| 2002 | 5 | 2 |
| 2003 | 6 | 6 |
| 2004 | 4 | 9 |
| 2005 | 1 | 7 |
| 2006 | 2 | 7 |
| 2007 | 4 | 6 |
| 2008 | 2 | 9 |
| 2009 | 3 | 10 |
| 2010 | 4 | 8 |
| 2011 | 10 | 16 |
| 2012 | 10 | 14 |
| 2013 | 13 | 17 |
| 2014 | 14 | 17 |
| 2015 | 19 | 10 |
| 2016 | 8 | 17 |
| 2017 | 13 | 13 |
| 2018 | 10 | 12 |
| 2019 | 9 | 10 |
| 2020 | 6 | 14 |
| 2021 | 11 | 17 |
| 2022 | 8 | 10 |
| 2023 | 7 | 19 |
| 2024 | 7 | 13 |
| 2025 | 12 | 20 |
| 2026 | 9 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Agrochemical compounds11 Aug 2026US 12,702,134 B2Syngenta Crop Protection AG
- Inhibitors of myeloperoxidase4 Aug 2026US 12,698,282 B2AstraZeneca AB
- Macrocyclic compounds, a process for their preparation and pharmaceutical compositions containing them2 Jun 2026US 12,643,912 B2Les Laboratoires Servier
- EP2 antagonist compounds12 May 2026US 12,624,024 B2Reservoir Neuroscience, Inc.
- Substituted indoles with inhibitory activity21 Apr 2026US 12,606,557 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Aryl hydrocarbon receptor modulator and use thereof6 Aug 2026US 2026/0226041 A1Arigenx Therapeutics Co., Ltd.
- Compounds with immunomodulatory activity and therapeutic uses thereof30 Jul 2026US 2026/0217665 A1Purdue Research Foundation
- Glp-1 agonists and methods of use4 Jun 2026US 2026/0151392 A1Biolexis Therapeutics, Inc.
- Aminopyridine derivatives and their use as selective alk-2 inhibitors30 Apr 2026US 2026/0116869 A1Novartis AG
- Inhibitors of CDK8 and CDK1916 Apr 2026US 2026/0103458 A1University of Dundee
Most cited
By later US patents
- 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation222US 5,616,601 AG. D. Searle & Co. · 1997
- Inhibitors of microsomal triglyceride transfer protein and method137US 5,712,279 ABristol-Myers Squibb Company · 1998
- Inhibitors of microsomal triglyceride transfer protein and method129US 5,739,135 ABristol-Myers Squibb Company · 1998
- Fused-ring compounds and use thereof as drugs67US 6,770,666 B2Japan Tobacco Inc. · 2004
- Compounds and methods for the treatment or prevention of Flavivirus infections65US 6,881,741 B2ViroChem Pharma Inc. · 2005